267.

Blackburn P, Projan SJ, Goldberg EB (Applied Microbiology, Inc.) Pharmaceutical bacteriocin compositions. PCT Int. Appl. WO 93 13,793 (Cl. A61K37/02), 22 Jul 1993, US Appl. 822,433. 17 Jan 1992; 35 pp. (CA) [A compn. contg. bacteriocin and chelator in an acidic vehicle is effective for preventing or treating gastrointestinal disorders caused by pathogenic microorganisms. Thus, EDTA-activated nisin was bactericidal toward Escherichia coli in the presence of various acid vehicles including acetate, citrate, lactate, and succinate. An oral compn. contg. nisin 0.01 and Na citrate (chelator) 1.0% was formulated.]

Gordon Research Institute / Reference Material

Gordon Research Institute    Dr. Garry F. Gordon MD DO MD(H)
600 N Beeline Hwy, Suite B, Payson, AZ 85541
Phone: 928-472-4263    Fax: 928-474-3819
Email Dr.Gordon